Published in Gene Therapy Weekly, October 30th, 2003
"We have been developing a new gene delivery method using a styrenated gelatin-based tissue-adhesive matrix that allows in situ adenovirus-immobilized gel formation on living tissue and sustained virus release to permeate carcinoma tissue. Styrenated gelatin was synthesized by the condensation reaction of gelatin with 4-vinylbenzoic acid. Aqueous styrenated gelatin solution premixed with AdLacZ, adenovirus encoding beta-galactosidase cDNA, and carboxylated camphorquinone (CQ) as a photoinitiator was irradiated with visible light to form a styrenated gelatin gel," according to researchers in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-10-30)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.